Towards Healthcare
PFAS Testing Market Size Reaches USD 1825.21 Billion by 2034

PFAS Testing Market Forecast 2025 How AI and Green Chemistry Will Shape a Future

According to forecasts, the global PFAS testing market will grow from USD 469.61 million in 2024 to USD 1825.21 million by 2034, with an expected CAGR of 14.54%. Across the globe, the market is fueled by escalating awareness of PFAS's potential health effects, such as linked to different health issues. From this, North America dominated the market due to U.S. EPA regulations and legal frameworks.

  • Insight Code: 5903
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

FAQ's

The PFAS testing market is projected to reach USD 1825.21 million by 2034, growing at a CAGR of 14.54% from 2024 to 2034

North America is currently leading the PFAS testing market due to U.S. EPA regulations and legal settlements, and growing awareness among the public.

The PFAS testing market includes four segments, such as by matrix type, by testing method, by service provider, and by region etc.

Some key players include Eurofins Scientific, SGS SA, ALS Limited, Agilent Technologies, and Waters Corporation.

Major concerns about PFAS are the potential health risks, such as impacts on growth, development, and reproduction, associated with hormone disruption, high cholesterol, immune system issues, and increased cancer risk.

Examples of PFAS testing in wastewater management are municipal wastewater treatment plans, industrial wastewater, and land application of biosolids.

NIH, US FDA, US EPA, NIEHS, ATSDR.GOV, DOE.GOV, USGS.GOV, NMW, ITA.GOV